Non-Tb Mycobacteria Inhaled Antibiotics

4 months ago, Wed, Sep 6, 2017, 23:49:45
Aradigm is uniquely positioned to develop a portfolio of its own products to treat patients with severe respiratory diseases. Aradigm is an emerging specialty pharmaceutical company developing and commercializing a portfolio of drugs delivered by inhalation for the treatment of severe respiratory disease.

Comments